BioLineRx Ltd. (BLRX.TA)

ILA 5.8

(-9.38%)

Net Debt Summary of BioLineRx Ltd.

  • BioLineRx Ltd.'s latest annual net debt in 2023 was 7.33 Million USD , up 322.34% from previous year.
  • BioLineRx Ltd.'s latest quarterly net debt in 2024 Q1 was 5.32 Million USD , down -27.43% from previous quarter.
  • BioLineRx Ltd. reported annual net debt of 1.73 Million USD in 2022, up 120.83% from previous year.
  • BioLineRx Ltd. reported annual net debt of -8.33 Million USD in 2021, up 8.83% from previous year.
  • BioLineRx Ltd. reported quarterly net debt of 21.63 Million USD for 2024 Q2, up 306.31% from previous quarter.
  • BioLineRx Ltd. reported quarterly net debt of 7.33 Million USD for 2023 FY, up 322.34% from previous quarter.

Annual Net Debt Chart of BioLineRx Ltd. (2023 - 2011)

Historical Annual Net Debt of BioLineRx Ltd. (2023 - 2011)

Year Net Debt Net Debt Growth
2023 7.33 Million USD 322.34%
2022 1.73 Million USD 120.83%
2021 -8.33 Million USD 8.83%
2020 -9.14 Million USD -277.34%
2019 5.15 Million USD -3.21%
2018 5.32 Million USD 209.65%
2017 -4.86 Million USD -128.6%
2016 -2.12 Million USD 58.37%
2015 -5.1 Million USD 11.69%
2014 -5.78 Million USD 34.8%
2013 -8.86 Million USD 51.42%
2012 -18.25 Million USD -112.84%
2011 -8.57 Million USD 0.0%

Peer Net Debt Comparison of BioLineRx Ltd.

Name Net Debt Net Debt Difference
Matricelf Ltd -835 Thousand ILA 978.563%